Exact Mass: 499.12987620000007
Exact Mass Matches: 499.12987620000007
Found 149 metabolites which its exact mass value is equals to given mass value 499.12987620000007
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5-O-(Indol-3-ylacetyl-myo-inositol) D-galactoside
C22H29NO12 (499.16896740000004)
Halofantrine
Halofantrine is a drug used to treat malaria. It belongs to the phenanthrene class of compounds that includes quinine and lumefantrine. It appears to inhibit polymerisation of heme molecules (by the parasite enzyme heme polymerase), resulting in the parasite being poisoned by its own waste. Halofantrine has been shown to preferentially block open and inactivated HERG channels leading to some degree of cardiotoxicity. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Suplatast Tosilate
C23H33NO7S2 (499.16983480000005)
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D018926 - Anti-Allergic Agents
VX-11e
VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK with Ki < 2 nM.
CDK9 inhibitor
C26H21N5O4S (499.1314186000001)
Glucose lactate pyruvate glutamate
C17H25NO16 (499.11732900000004)
Palygorskite
It is used in foods as a clarifying and flocculating agent [DFC]
5-O-beta-D-glucopyranosyldihydroneoascorbigen
C22H29NO12 (499.16896740000004)
Cys Cys Phe Gln
Cys Cys Gln Phe
Cys Phe Cys Gln
Cys Phe Gln Cys
Cys Asn Thr Tyr
C20H29N5O8S (499.17367540000004)
Cys Asn Tyr Thr
C20H29N5O8S (499.17367540000004)
Cys Gln Cys Phe
Cys Gln Phe Cys
Cys Gln Ser Tyr
C20H29N5O8S (499.17367540000004)
Cys Gln Tyr Ser
C20H29N5O8S (499.17367540000004)
Cys Ser Gln Tyr
C20H29N5O8S (499.17367540000004)
Cys Ser Tyr Gln
C20H29N5O8S (499.17367540000004)
Cys Thr Asn Tyr
C20H29N5O8S (499.17367540000004)
Cys Thr Tyr Asn
C20H29N5O8S (499.17367540000004)
Cys Tyr Asn Thr
C20H29N5O8S (499.17367540000004)
Cys Tyr Gln Ser
C20H29N5O8S (499.17367540000004)
Cys Tyr Ser Gln
C20H29N5O8S (499.17367540000004)
Cys Tyr Thr Asn
C20H29N5O8S (499.17367540000004)
Asp Asp His Asn
Asp Asp Asn His
Asp His Asp Asn
Asp His Asn Asp
Asp Asn Asp His
Asp Asn His Asp
Phe Cys Cys Gln
Phe Cys Gln Cys
Phe Gln Cys Cys
His Asp Asp Asn
His Asp Asn Asp
His Asn Asp Asp
Asn Cys Thr Tyr
C20H29N5O8S (499.17367540000004)
Asn Cys Tyr Thr
C20H29N5O8S (499.17367540000004)
Asn Asp Asp His
Asn Asp His Asp
Asn His Asp Asp
Asn Thr Cys Tyr
C20H29N5O8S (499.17367540000004)
Asn Thr Tyr Cys
C20H29N5O8S (499.17367540000004)
Asn Tyr Cys Thr
C20H29N5O8S (499.17367540000004)
Asn Tyr Thr Cys
C20H29N5O8S (499.17367540000004)
Gln Cys Cys Phe
Gln Cys Phe Cys
Gln Cys Ser Tyr
C20H29N5O8S (499.17367540000004)
Gln Cys Tyr Ser
C20H29N5O8S (499.17367540000004)
Gln Phe Cys Cys
Gln Ser Cys Tyr
C20H29N5O8S (499.17367540000004)
Gln Ser Tyr Cys
C20H29N5O8S (499.17367540000004)
Gln Tyr Cys Ser
C20H29N5O8S (499.17367540000004)
Gln Tyr Ser Cys
C20H29N5O8S (499.17367540000004)
Ser Cys Gln Tyr
C20H29N5O8S (499.17367540000004)
Ser Cys Tyr Gln
C20H29N5O8S (499.17367540000004)
Ser Gln Cys Tyr
C20H29N5O8S (499.17367540000004)
Ser Gln Tyr Cys
C20H29N5O8S (499.17367540000004)
Ser Tyr Cys Gln
C20H29N5O8S (499.17367540000004)
Ser Tyr Gln Cys
C20H29N5O8S (499.17367540000004)
Thr Cys Asn Tyr
C20H29N5O8S (499.17367540000004)
Thr Cys Tyr Asn
C20H29N5O8S (499.17367540000004)
Thr Asn Cys Tyr
C20H29N5O8S (499.17367540000004)
Thr Asn Tyr Cys
C20H29N5O8S (499.17367540000004)
Thr Tyr Cys Asn
C20H29N5O8S (499.17367540000004)
Thr Tyr Asn Cys
C20H29N5O8S (499.17367540000004)
Tyr Cys Asn Thr
C20H29N5O8S (499.17367540000004)
Tyr Cys Gln Ser
C20H29N5O8S (499.17367540000004)
Tyr Cys Ser Gln
C20H29N5O8S (499.17367540000004)
Tyr Cys Thr Asn
C20H29N5O8S (499.17367540000004)
Tyr Asn Cys Thr
C20H29N5O8S (499.17367540000004)
Tyr Asn Thr Cys
C20H29N5O8S (499.17367540000004)
Tyr Gln Cys Ser
C20H29N5O8S (499.17367540000004)
Tyr Gln Ser Cys
C20H29N5O8S (499.17367540000004)
Tyr Ser Cys Gln
C20H29N5O8S (499.17367540000004)
Tyr Ser Gln Cys
C20H29N5O8S (499.17367540000004)
Tyr Thr Cys Asn
C20H29N5O8S (499.17367540000004)
Tyr Thr Asn Cys
C20H29N5O8S (499.17367540000004)
Fosquidone
C28H22NO6P (499.11846820000005)
C274 - Antineoplastic Agent > C177298 - Mitochondrial Targeting Antineoplastic Agent C26170 - Protective Agent > C275 - Antioxidant
1,4,8-Tris(aminocarbonylmethyl)-1,4,8,11-tetraazacyclotetradecane monohydriodide
4-nitrobenzyl [2R-(2alpha,5beta,6alpha,7beta)]-3-methylene-8-oxo-7-(phenoxyacetamido)-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylate 5-oxide
C23H21N3O8S (499.10493060000005)
N-[4-(aminocarbonyl)phenyl]-4-[[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]azo]benzamide
C25H21N7O5 (499.16040960000004)
Sodelglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
2-(3,4-Difluorophenoxy)-5-fluoro-N-(cis-4-((2-hydroxy-5-methylbenzoyl)amino)cyclohexyl)nicotinamide
C26H24F3N3O4 (499.17188200000004)
Pivampicillin hydrochloride
C22H30ClN3O6S (499.1543750000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-[(2-isopropyl-3-oxo-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)thio]acetamide
n-[4-[[Glutamic acid]-carbonyl]-benzene-sulfonyl-d-prolinyl]-3-amino-propanoic acid
C20H25N3O10S (499.12605900000005)
3-(5-Amino-7-hydroxy-[1,2,3]triazolo[4,5-D]pyrimidin-2-YL)-N-[2-(2-(hydroxymethyl-phenylsulfanyl)-benzyl]-benzamide
N-(2H-benzotriazol-5-yl)-7-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]quinolin-4-amine
(2R)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoate
[(1R,2R,3R,4R,5S,6R)-2,3,4,5-tetrahydroxy-6-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexyl] 2-(1H-indol-3-yl)acetate
C22H29NO12 (499.16896740000004)
(2S)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoate
5-O-(2-hydroxypropanoyl) 1-O-(2-oxopropanoyl) 2-amino-2-[2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]pentanediperoxoate
C17H25NO16 (499.11732900000004)
(2S)-2-[3-[3-(trifluoromethyl)-4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide
C22H19F6N5O2 (499.14428660000004)
5-O-(indol-3-ylacetyl)-myo-inositol D-galactoside
C22H29NO12 (499.16896740000004)
N-(1,3-benzodioxol-5-ylmethyl)-1-ethyl-6-(4-morpholinylsulfonyl)-4-oxo-3-quinolinecarboxamide
[4-(2-Chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(phenylmethyl)-1-piperazinyl]methanone
C24H22ClN3O5S (499.0968632000001)
4-Methyl-7-[[4-[[4-(4-nitrophenyl)-1-piperazinyl]-oxomethyl]phenyl]methoxy]-1-benzopyran-2-one
3-[[2-[[5-[(4-Cyanophenoxy)methyl]-4-phenyl-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]benzoic acid methyl ester
C26H21N5O4S (499.1314186000001)
1-(1,3-benzodioxol-5-ylmethyl)-3-(4-methylphenyl)-1-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]urea
1-methyl-5-(piperidin-1-ylsulfonyl)-1H-indole-3-carbaldehyde N-(2-ethoxyphenyl)thiosemicarbazone
8-chloro-1-methyl-2,6-dioxo-7H-purine-3-carboxylic acid 2-(diphenylmethyl)oxy-N,N-dimethylethanamine
C24H26ClN5O5 (499.1622376000001)
[(1R)-2-(1,3-benzodioxol-5-ylmethyl)-1-ethylsulfonyl-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C25H29N3O6S (499.17769740000006)
[(1S)-2-(1,3-benzodioxol-5-ylmethyl)-1-ethylsulfonyl-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C25H29N3O6S (499.17769740000006)
4-(4-Chlorobenzoyl)-1-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-5-phenylpyrrolidine-2,3-dione
C28H22ClN3O4 (499.12987620000007)
(2R)-2-amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-oxidocarbonimidoyl]phenoxy]butanoic acid
(2S)-2-amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-oxidocarbonimidoyl]phenoxy]butanoic acid
Halofantrine
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
[(2S,3S,5R,6R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-cyclohexyl] 2-(1H-indol-3-yl)acetate
C22H29NO12 (499.16896740000004)
nocardicin A(1-)
An alpha-amino-acid anion that is the conjugate base of nocardicin A, arising from deprotonation of the carboxy groups and protonation of the amino group.
isonocardicin A(1-)
Conjugate base of isonocardicin A zwitterion where both carboxy groups are deprotonated while the homoserine amino group is protonated.
O-Indolylacetyl-inositol galactoside
C22H29NO12 (499.16896740000004)
RMC-0331
C22H25ClF3N5O3 (499.15979260000006)
RMC-0331 (RM-023) is a potent, selective and orally bioavailable SOS1 inhibitor. RMC-0331 is an in vivo tool compound that blocks RAS activation via disruption of the RAS-SOS1 interaction[1].
[(e)-(1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-2-(3,4,5-trimethoxyphenyl)ethylidene)amino]oxysulfonic acid
(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-yl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid
C21H29N3O9S (499.16244240000003)
7,17-dihydroxy-12-(3-hydroxy-4-methoxyphenyl)-8,16-dimethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17,20-nonaen-3-one
(2e)-3-(4-{[(2s,3s,4s,5s)-5-acetyl-3,4-dihydroxyoxolan-2-yl]oxy}-3-hydroxyphenyl)-2-methyl-n-[(2r,3s,5r,6s)-2,3,4,5,6-pentahydroxycyclohexyl]prop-2-enimidic acid
C22H29NO12 (499.16896740000004)
(2s,3r,4s,5s,6r)-2-{[(2r,3r,6z)-3-hydroxy-6-(methoxyimino)-2,3-dihydrothiopyran-2-yl]oxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
C18H29NO13S (499.13595440000006)
2-[6-(2,4-dihydroxy-6-methylbenzoyloxy)-4-hydroxy-5-(3-methylbut-2-en-1-yl)-1-oxo-3h-isoindol-2-yl]butanedioic acid
4-[(6as)-5-chloro-6a-methyl-9-[(2e)-2-methylbut-2-enoyl]-3-[(1e,3s)-3-methylpent-1-en-1-yl]-6,8-dioxofuro[2,3-h]isoquinolin-2-yl]butanoic acid
C27H30ClNO6 (499.17615500000005)
(3s,4r,5s)-3,4-dihydroxy-5-[(1s)-2-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl]-3-[(1-methoxyindol-3-yl)methyl]oxolan-2-one
C22H29NO12 (499.16896740000004)
3,4-dihydroxy-5-(2-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-3-[(1-methoxyindol-3-yl)methyl]oxolan-2-one
C22H29NO12 (499.16896740000004)
4-[5-chloro-6a-methyl-9-(2-methylbut-2-enoyl)-3-(3-methylpent-1-en-1-yl)-6,8-dioxofuro[2,3-h]isoquinolin-2-yl]butanoic acid
C27H30ClNO6 (499.17615500000005)
4-[(6as)-5-chloro-6a-methyl-9-(2-methylbut-2-enoyl)-3-[(3s)-3-methylpent-1-en-1-yl]-6,8-dioxofuro[2,3-h]isoquinolin-2-yl]butanoic acid
C27H30ClNO6 (499.17615500000005)
(2s)-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-sulfanylethyl]-c-hydroxycarbonimidoyl}-2-{[(2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-yl]amino}butanoic acid
C21H29N3O9S (499.16244240000003)
2-amino-4-{[1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-yl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid
C21H29N3O9S (499.16244240000003)